Literature DB >> 30025198

Regression of hepatocellular adenoma after bariatric surgery in severe obese patients.

Tom J G Gevers1, B W Marcel Spanier1, Peter B Veendrick2, Jan Maarten Vrolijk1.   

Abstract

BACKGROUND & AIM: Obesity and metabolic syndrome are increasingly recognized as risk factors for hepatocellular adenomas (HCA). There is still sparse evidence whether weight loss or bariatric surgery could induce HCA regression in these patients. In this brief report we describe the effect of weight loss on HCA regression in severe obese patients that had undergone bariatric surgery in our centre.
METHODS: We performed an Electronic Patient Database search and included all patients who underwent bariatric surgery in our bariatric referral centre and had an ICD-10 code of benign neoplasm of liver in our centre from (2006-2017). All imaging studies of eligible patients were re-evaluated by the study radiologist. Primary outcome was change in maximal diameter of HCA.
RESULTS: Six of 11 eligible patients were excluded because their lesions were classified as probable focal nodular hyperplasia and two were lost to follow-up. Finally, three women with solitary (n = 1) or multiple HCA (n = 2) and a body mass index (BMI) ranging between 39 and 50 kg/m2 were included. In two patients, HCA completely regressed in 1-2 years following bariatric surgery, after BMI reductions of 36%-48%. The third patient showed a reduction of >50% in diameter of the largest HCA in 2.5 years after bariatric surgery (31% BMI reduction), with complete resolution of smaller HCA.
CONCLUSIONS: Bariatric induced weight loss results in significant regression of HCA in severe obese women, which emphasizes the role of overweight in HCA pathophysiology.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  liver adenoma; non-alcoholic fatty liver disease; obesity; roux-and-y gastric bypass

Mesh:

Year:  2018        PMID: 30025198     DOI: 10.1111/liv.13934

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

1.  Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.

Authors:  Paulo Herman; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Fabricio Ferreira Coelho
Journal:  J Gastrointest Surg       Date:  2020-07-14       Impact factor: 3.452

2.  Case of resected multiple hepatocellular adenomas in a young man with severe obesity.

Authors:  Kentaro Oji; Takeshi Urade; Yoshiteru Iwatani; Katsuhide Tanaka; Hirotaka Hirano; Tsuyoshi Sanuki; Masaru Tomita; Yuki Yamamoto; Yoh Zen; Daisuke Kuroda
Journal:  Surg Case Rep       Date:  2019-08-13

Review 3.  Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.

Authors:  Federica Vernuccio; Domenico Salvatore Gagliano; Roberto Cannella; Ahmed Ba-Ssalamah; An Tang; Giuseppe Brancatelli
Journal:  Insights Imaging       Date:  2021-01-12

4.  High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia.

Authors:  Martijn P D Haring; Fabian Peeks; Maaike H Oosterveer; Martijn C G J Brouwers; Carla E M Hollak; Mirian C H Janssen; Janneke G Langendonk; Alexander J M Rennings; Margreet A E M Wagenmakers; Henkjan J Verkade; Terry G J Derks; Vincent E de Meijer
Journal:  JHEP Rep       Date:  2022-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.